Aldemar B. Degroot, Ph.D.
Affiliations: | University of Alberta, Edmonton, Alberta, Canada |
Google:
"Aldemar Degroot"Mean distance: 18.38 (cluster 17) | S | N | B | C | P |
Parents
Sign in to add mentor| Dallas Treit | grad student | 2003 | University of Alberta | |
| (The role of the septo-hippocampal system in fear and anxiety.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Balcer OM, Seager MA, Gleason SD, et al. (2018) Evaluation of 5-HT receptor antagonism for the treatment of anxiety, depression, and schizophrenia through the use of receptor-deficient mice. Behavioural Brain Research. 360: 270-278 |
| Degroot A, Nomikos GG. (2005) Fluoxetine disrupts the integration of anxiety and aversive memories. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 391-400 |
| Degroot A, Nomikos GG. (2004) Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying test. The European Journal of Neuroscience. 20: 1059-64 |
| Degroot A, Wade M, Salhoff C, et al. (2004) Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: reversal by chlordiazepoxide. European Journal of Pharmacology. 493: 103-9 |
| Degroot A, Treit D. (2004) Anxiety is functionally segregated within the septo-hippocampal system. Brain Research. 1001: 60-71 |
| Degroot A, Kornecook T, Quirion R, et al. (2003) Glucose increases hippocampal extracellular acetylcholine levels upon activation of septal GABA receptors. Brain Research. 979: 71-7 |
| Degroot A, Treit D. (2003) Septal GABAergic and hippocampal cholinergic systems interact in the modulation of anxiety. Neuroscience. 117: 493-501 |
| Degroot A, Treit D. (2002) Dorsal and ventral hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Brain Research. 949: 60-70 |
| Degroot A, Parent MB. (2001) Infusions of physostigmine into the hippocampus or the entorhinal cortex attenuate avoidance retention deficits produced by intra-septal infusions of the GABA agonist muscimol. Brain Research. 920: 10-8 |
| Degroot A, Kashluba S, Treit D. (2001) Septal GABAergic and hippocampal cholinergic systems modulate anxiety in the plus-maze and shock-probe tests. Pharmacology, Biochemistry, and Behavior. 69: 391-9 |